| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |